These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24854566)

  • 1. Dose conversion factor between cyclosporine and tacrolimus in pediatric heart transplant recipients.
    Notaro E; Brown L; Albers E; Law S; Kemna M
    J Heart Lung Transplant; 2014 Jul; 33(7):766-8. PubMed ID: 24854566
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrolimus use in renal and cardiac pediatric transplantation: no increased risk of food allergies.
    Graham F; Racicot F; Jamali L; Cong VP; Raboisson MJ; Paradis J; Paradis L; Des Roches A
    Ann Allergy Asthma Immunol; 2015 Aug; 115(2):155-7. PubMed ID: 26094803
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between effects of cyclosporine and tacrolimus on glomerular filtration rate in pediatric post-orthotopic liver transplant patients.
    Loo RM; Ariyarajah V; Oh C; Shen L; Aw MM; Prabhakaran K
    Pediatr Transplant; 2006 Feb; 10(1):55-9. PubMed ID: 16499588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion from cyclosporine to tacrolimus in pediatric kidney transplant recipients.
    Ferraresso M; Ghio L; Edefonti A; Garavaglia R; Berardinelli L
    Pediatr Nephrol; 2002 Aug; 17(8):664-7. PubMed ID: 12185478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
    Melter M; Rodeck B; Kardorff R; Hoyer PF; Maibücher A; Brodehl J
    Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of tacrolimus as rescue therapy in children using a double immunosuppressive regimen after heart transplantation.
    Branco KC; Azeka E; Trindade E; Galas FR; Hajjar LA; Benvenuti L; Riso A; Tanamati C; Penha J; Auler JO; Jatene M
    Transplant Proc; 2012 Oct; 44(8):2483-5. PubMed ID: 23026625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trial of tacrolimus- vs cyclosporine-based immunosuppression in pediatric heart transplantation: preliminary results at 15-month follow-up.
    Pollock-Barziv SM; Dipchand AI; McCrindle BW; Nalli N; West LJ
    J Heart Lung Transplant; 2005 Feb; 24(2):190-4. PubMed ID: 15701436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children.
    Pollock-Barziv SM; Finkelstein Y; Manlhiot C; Dipchand AI; Hebert D; Ng VL; Solomon M; McCrindle BW; Grant D
    Pediatr Transplant; 2010 Dec; 14(8):968-75. PubMed ID: 21040278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact on biochemical profiles and allograft function for patients converted from cyclosporine to tacrolimus after clinical heart transplantation.
    Wang CH; Chou NK; Ko WJ; Chi NH; Tsao CI; Wang SS
    Transplant Proc; 2008 Oct; 40(8):2600-2. PubMed ID: 18929812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection.
    Meiser BM; Uberfuhr P; Fuchs A; Schmidt D; Pfeiffer M; Paulus D; Schulze C; Wildhirt S; Scheidt WV; Angermann C; Klauss V; Martin S; Reichenspurner H; Kreuzer E; Reichart B
    J Heart Lung Transplant; 1998 Aug; 17(8):782-8. PubMed ID: 9730427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients.
    Hmiel SP; Canter C; Shepherd R; Lassa-Claxton S; Nadler M
    Pediatr Transplant; 2007 Aug; 11(5):524-9. PubMed ID: 17631021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
    J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early renal benefit of rapamycin combined with reduced calcineurin inhibitor dose in pediatric heart transplantation patients.
    Balfour IC; Srun SW; Wood EG; Belsha CW; Marshall DL; Ferdman BR
    J Heart Lung Transplant; 2006 May; 25(5):518-22. PubMed ID: 16678029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from tacrolimus to cyclosporine microemulsion therapy in liver transplant recipients.
    Ogino S; Hashikura Y; Katsuyama Y; Ikegami T; Nakazawa Y; Urata K; Terada M; Miyagawa S; Kawasaki S
    Transplant Proc; 2004 Mar; 36(2 Suppl):299S-301S. PubMed ID: 15041357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up after conversion to Neoral in stable heart transplant recipients.
    Pethig K; Geiger M; Korn A; Grote M; Christians U; Wahlers T
    Transplant Proc; 1996 Aug; 28(4):2282-4. PubMed ID: 8769226
    [No Abstract]   [Full Text] [Related]  

  • 17. Converting immunosuppression from an oral suspension to a granule formulation of tacrolimus in pediatric renal transplant recipients.
    Malakasioti G; Booth C; Marks SD
    Pediatr Transplant; 2018 Aug; 22(5):e13214. PubMed ID: 29767471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes associated with conversion to tacrolimus-based immunosuppression in pediatric cardiac transplantation.
    Walker RE; McCrindle BW; Coles JG; West LJ
    Transplant Proc; 1998 Jun; 30(4):1116-7. PubMed ID: 9636452
    [No Abstract]   [Full Text] [Related]  

  • 19. Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.
    Manlhiot C; Pollock-Barziv SM; Holmes C; Weitzman S; Allen U; Clarizia NA; Ngan BY; McCrindle BW; Dipchand AI
    J Heart Lung Transplant; 2010 Jun; 29(6):648-57. PubMed ID: 20304682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy and safety of conversion to tacrolimus in heart transplant recipients with ongoing or recurrent acute cellular rejection.
    Skalická B; Málek I; Kubánek M; Vymětalová J; Kautzner J
    Physiol Res; 2010; 59(3):379-384. PubMed ID: 19681656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.